234 related articles for article (PubMed ID: 25762713)
21. Informed Consent in IBD Trials: Where We Are and Where We Need to Go.
Kurin M; Katz J; Kodish E; Lashner B
Inflamm Bowel Dis; 2019 Jun; 25(7):1115-1119. PubMed ID: 30989217
[TBL] [Abstract][Full Text] [Related]
22. Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
Lhomme E; Modet C; Augier A; Faye S; Dabakuyo-Yonli TS; Levy-Marchal C; D'Ortenzio E; Yazdanpanah Y; Chêne G; Beavogui AH; Richert L;
Trials; 2019 Jul; 20(1):422. PubMed ID: 31296253
[TBL] [Abstract][Full Text] [Related]
23. A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion.
Furman CD; Earnshaw LA; Doukas DJ; Farrer LA; Friedland RP
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):590-5. PubMed ID: 24615498
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics.
Tuszynski MH; Steeves JD; Fawcett JW; Lammertse D; Kalichman M; Rask C; Curt A; Ditunno JF; Fehlings MG; Guest JD; Ellaway PH; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Privat A;
Spinal Cord; 2007 Mar; 45(3):222-31. PubMed ID: 17179971
[TBL] [Abstract][Full Text] [Related]
25. Disclosure of individualized research results: a precautionary approach.
Resnik DB
Account Res; 2011 Nov; 18(6):382-97. PubMed ID: 22011068
[TBL] [Abstract][Full Text] [Related]
26. Study partners should be required in preclinical Alzheimer's disease trials.
Grill JD; Karlawish J
Alzheimers Res Ther; 2017 Dec; 9(1):93. PubMed ID: 29212555
[TBL] [Abstract][Full Text] [Related]
27. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?
Cox CG; Ryan MM; Gillen DL; Grill JD
J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225
[TBL] [Abstract][Full Text] [Related]
28. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
[TBL] [Abstract][Full Text] [Related]
29. Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent.
Whitesides LW; Baren JM; Biros MH; Fleischman RJ; Govindarajan PR; Jones EB; Pancioli AM; Pentz RD; Scicluna VM; Wright DW; Dickert NW
Clin Trials; 2017 Apr; 14(2):180-186. PubMed ID: 28359192
[TBL] [Abstract][Full Text] [Related]
30. Misconceptions about coercion and undue influence: reflections on the views of IRB members.
Largent E; Grady C; Miller FG; Wertheimer A
Bioethics; 2013 Nov; 27(9):500-7. PubMed ID: 22493972
[TBL] [Abstract][Full Text] [Related]
31. Does informed consent to research require comprehension?
Sreenivasan G
Lancet; 2003 Dec; 362(9400):2016-8. PubMed ID: 14683665
[No Abstract] [Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Consent in Alzheimer's disease research: risk/benefit factors.
Beattie BL
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S27-31. PubMed ID: 17469678
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
35. Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
Cole JB; Klein LR; Mullinax SZ; Nordstrom KD; Driver BE; Wilson MP
Acad Emerg Med; 2019 May; 26(5):559-566. PubMed ID: 30548977
[TBL] [Abstract][Full Text] [Related]
36. Provision of consent.
Chalmers I
Lancet; 2003 Aug; 362(9384):663-4. PubMed ID: 12944068
[No Abstract] [Full Text] [Related]
37. Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.
Banja JD; Dunlop B
Am J Bioeth; 2009 Aug; 9(8):39-41. PubMed ID: 19998159
[No Abstract] [Full Text] [Related]
38. Trends in Consent for Clinical Trials in Cardiovascular Disease.
Kerkhoff LA; Butler J; Kelkar AA; Shore S; Speight CD; Wall LK; Dickert NW
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317350
[TBL] [Abstract][Full Text] [Related]
39. Public Deliberation as a Novel Method for an Exception From Informed Consent Community Consultation.
Powers PE; Shore KK; Perez S; Ritley D; Kuppermann N; Holmes JF; Tzimenatos LS; Shawargga H; Nishijima DK
Acad Emerg Med; 2019 Oct; 26(10):1158-1168. PubMed ID: 31271691
[TBL] [Abstract][Full Text] [Related]
40. Clinical research with healthy volunteers: an ethical framework.
Miller FG
J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
